Users of STANOVER (Stanozolol injectable) often report good gains in strength, vascularity, and muscle tone. People often report very intense muscle "pumps" during workouts when using this compound. Some studies have also shown that STANOVER (Stanozolol injectable) has estrogen and progesterone blocking abilities, making it a good choice to use with other steroids such as Testosterone, Nandrolone, or Trenbolone. STANOVER (Stanozolol injectable) also does a very good job of reducing the amount of SHBG in the body, thus allowing other steroids to be much more abundant in their free state in the body. Due to this fact, STANOVER (Stanozolol injectable) makes a great addition to all cycles.
To strengthen the anabolic properties of testosterone, more than 100 synthetic steroid derivatives have been described for human purposes. The anabolic effect promotes protein synthesis, muscle growth and erythropoiesis. In clinical practice, substances with anabolic effect are needed to overcome various catabolic states. However, none of these compounds are devoid of androgenicity. Androgenic and anabolic properties of anabolic steroids cannot be totally separated. Therefore, it is more appropriate to use the term anabolic androgenic steroids (AAS).
Metabolic effects occurring during anabolic steroid therapy in immobilized patients or those with metastatic breast disease include osteolytic-induced hypercalcemia .
Anabolic steroids effect electrolyte balance, nitrogen retention, and urinary calcium excretion. Edema, with and without congestive heart failure, has occurred during anabolic steroid therapy.
The androgenic activity of anabolic steroids may decrease levels of thyroxin-binding globulin, resulting in decreased total T4 serum levels and increased resin uptake of T3 and T4. Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction.
Significant increases in low density lipoproteins (LDL) and decreases in high density lipoproteins (HDL) have occurred. [ Ref ]